Showing results (951-960 of 973) with videos related to

Sort By:
Pageof 98
Bioorganic & Medicinal Chemistry Letters|March 29, 2011
Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonistQingmei Hong, Raman K Bakshi, Brenda L Palucki, et al.
Nature|July 14, 2000
Identification of receptors for neuromedin U and its role in feedingA D Howard, R Wang, S S Pong, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesityShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Cell Metabolism|January 26, 2010
Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesityXiao-Ming Guan, Howard Chen, Peter H Dobbelaar, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|May 13, 2024
The DESTINY<sup>+</sup> Dust Analyser - a dust telescope for analysing cosmic dust dynamics and compositionJonas Simolka, Roberto Blanco, Stephan Ingerl, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2007
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodentsTung M Fong, Xiao-Ming Guan, Donald J Marsh, et al.
Bioorganic & Medicinal Chemistry|April 13, 2012
The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerizationHarry R Chobanian, Yan Guo, Ping Liu, et al.
Plos One|October 8, 2014
MCL1 and BCL-xL levels in solid tumors are predictive of dinaciclib-induced apoptosisRobert N Booher, Harold Hatch, Brian M Dolinski, et al.
The Journal of Clinical Investigation|February 6, 2019
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growthShaikamjad Umesalma, Courtney A Kaemmer, Jordan L Kohlmeyer, et al.
Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonistShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Pageof 98